ClinicalTrials.Veeva

Menu

Feasibility and Safety of a Single Working Element for Bipolar and Laser Enucleation in Prostate Surgery: A Prospective Study

M

Menoufia University

Status

Enrolling

Conditions

Prostate
BPH (Benign Prostatic Hyperplasia)

Treatments

Device: A single working element for laser enucleation
Device: A single working element for bipolar enucleation

Study type

Observational

Funder types

Other

Identifiers

NCT07020364
Enucleation of prostate

Details and patient eligibility

About

A prospective feasibility study would be a practical first step, focusing on real-time assessment and ensuring the new working element's integration is safe and effective before broader clinical trials.

Enrollment

60 estimated patients

Sex

Male

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with benign prostatic hyperplasia (BPH) requiring surgical intervention.
  • Prostate volume ≥40 cc (as assessed by transrectal ultrasound).
  • No prior history of prostate cancer.

Exclusion criteria

  • Patients with ongoing urinary tract infections.
  • Prior prostate surgeries.
  • Coagulation disorders or patients on long-term anticoagulation therapy.
  • Known urethral strictures or other anatomical abnormalities complicating endoscopic procedures.

Trial design

60 participants in 2 patient groups

Bipolar Enucleation
Description:
Bipolar Enucleation Group: The bipolar energy will be used for cutting and coagulation during enucleation.
Treatment:
Device: A single working element for bipolar enucleation
Laser Enucleation
Description:
Laser Enucleation Group: Thulium or Holmium laser will be employed for tissue dissection and hemostasis.
Treatment:
Device: A single working element for laser enucleation

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed K Omar, Assistant professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems